How much funding has Iambic Therapeutics raised?

Iambic Therapeutics has raised $100.0M in total funding, most recently a Venture Round.

When was Iambic Therapeutics founded?

Iambic Therapeutics was founded in 2019.

Where is Iambic Therapeutics headquartered?

Iambic Therapeutics is headquartered in San Diego, California, United States.

What industry is Iambic Therapeutics in?

Iambic Therapeutics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Iambic Therapeutics have?

Iambic Therapeutics has 51-200 employees.

Iambic Therapeutics

Charting new paths to superior medicines

San Diego, United States · Founded 2019 · $100.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: iambic.ai
Total Funding: $100.0M
Last Round: $100.0M Venture RoundNov 2025
Rounds: 1

About

Iambic Therapeutics is a clinical-stage life-sciences and technology company developing novel medicines using its AI-driven discovery and development platform. Founded in 2019 and headquartered in San Diego, California, Iambic combines physics-based AI algorithms with high-throughput experimentation to tackle the most challenging design problems in drug discovery. The company's platform converts new molecular designs to new biological insights each week, enabling it to identify first-in-class and best-in-class drug candidates years faster than industry norms. Iambic's pipeline includes HER2 and CDK2/4 programs in oncology, with its lead HER2 program in Phase 1 clinical studies.

Summary

Iambic Therapeutics is an Artificial Intelligence company based in San Diego, United States, founded in 2019. It has raised $100.0M in total across 1 round, most recently a $100.0M Venture Round round in Nov 2025.

LinkedIn X (Twitter)